GE chief Larry Culp sells biopharma business for $21 billion

GE chief Larry Culp sells biopharma business for $21 billion Culp said the sale to Danaher, where he was chief executive for more than a decade until 2014, was a pivotal milestone in efforts to turn around the 126-year old conglomerate.

No comments:

Post a Comment